Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Reperfusion injury
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
=== Cannabinoids === A study published in 2012 show that the [[Synthetic cannabinoids|synthetic]] analogue of the [[Cannabinoid|phytocannabinoid]] [[Tetrahydrocannabivarin]] (THCV), Δ<sup>8</sup>-Tetrahydrocannabivarin (Δ<sup>8</sup>-THCV) and its [[metabolite]] 11-OH-Δ<sup>8</sup>-THCV, prevent [[Liver|hepatic]] [[Ischemia|ischaemia]]/reperfusion injury by decreasing [[oxidative stress]] and [[Inflammation|inflammatory]] responses through cannabinoid [[Cannabinoid receptor type 2|CB2 receptors]] and thereby decrease tissue injury and inflammation with a protective effect against liver damage. Pretreatment with a CB2 [[receptor antagonist]] attenuated the protective effects of Δ<sup>8</sup>-THCV, while a [[Cannabinoid receptor type 1|CB1]] [[Cannabinoid receptor antagonist|antagonist]] tended to enhance it.<ref>{{cite journal |last1=Bátkai |first1=Sándor |last2=Mukhopadhyay |first2=Partha |last3=Horváth |first3=Bėla |last4=Rajesh |first4=Mohanraj |last5=Gao |first5=Rachel Y |last6=Mahadevan |first6=Anu |last7=Amere |first7=Mukkanti |last8=Battista |first8=Natalia |last9=Lichtman |first9=Aron H |last10=Gauson |first10=Lisa A |last11=Maccarrone |first11=Mauro |last12=Pertwee |first12=Roger G |last13=Pacher |first13=Pál |title=Δ8-Tetrahydrocannabivarin prevents hepatic ischaemia/reperfusion injury by decreasing oxidative stress and inflammatory responses through cannabinoid CB2 receptors: Δ8-Tetrahydrocannabivarin for reperfusion injury |journal=British Journal of Pharmacology |date=April 2012 |volume=165 |issue=8 |pages=2450–2461 |doi=10.1111/j.1476-5381.2011.01410.x |pmid=21470208 |pmc=3423240 }}</ref> An earlier study published in 2011 found, that [[Cannabidiol]] (CBD) also protects against hepatic ischemia/reperfusion injury by attenuating inflammatory signaling and response of oxidative and [[Nitrate|nitrative]] stress, and thereby [[cell death]] and [[Tissue (biology)|tissue]] injury, but independent from classical CB1 and CB2 receptors.<ref>{{cite journal |last1=Mukhopadhyay |first1=Partha |last2=Rajesh |first2=Mohanraj |last3=Horváth |first3=Béla |last4=Bátkai |first4=Sándor |last5=Park |first5=Ogyi |last6=Tanchian |first6=Galin |last7=Gao |first7=Rachel Y. |last8=Patel |first8=Vivek |last9=Wink |first9=David A. |last10=Liaudet |first10=Lucas |last11=Haskó |first11=György |last12=Mechoulam |first12=Raphael |last13=Pacher |first13=Pál |title=Cannabidiol protects against hepatic ischemia/reperfusion injury by attenuating inflammatory signaling and response, oxidative/nitrative stress, and cell death |journal=Free Radical Biology and Medicine |date=May 2011 |volume=50 |issue=10 |pages=1368–1381 |doi=10.1016/j.freeradbiomed.2011.02.021 |pmid=21362471 |pmc=3081988 }}</ref>
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)